Abstract

Microsatellite instability (MSI) represents one of the major types of genomic instability in human cancers and is most common in colorectal cancer (CRC) and endometrial cancer (EC). MSI develops as a consequence of DNA mismatch repair (MMR) deficiency, which can occur sporadically or in the context of Lynch syndrome (LS), the most common inherited tumor syndrome. MMR deficiency triggers the accumulation of high numbers of somatic mutations in the affected cells, mostly indel mutations at microsatellite sequences. MSI tumors are among the most immunogenic human tumors and are often characterized by pronounced local immune responses. However, so far, little is known about immunological differences between sporadic and hereditary MSI tumors. Therefore, a systematic literature search was conducted to comprehensively collect data on the differences in local T cell infiltration and immune evasion mechanisms between sporadic and LS-associated MSI tumors. The vast majority of collected studies were focusing on CRC and EC. Generally, more pronounced T cell infiltration and a higher frequency of B2M mutations were reported for LS-associated compared to sporadic MSI tumors. In addition, phenotypic features associated with enhanced lymphocyte recruitment were reported to be specifically associated with hereditary MSI CRCs. The quantitative and qualitative differences clearly indicate a distinct biology of sporadic and hereditary MSI tumors. Clinically, these findings underline the need for differentiating sporadic and hereditary tumors in basic science studies and clinical trials, including trials evaluating immune checkpoint blockade therapy in MSI tumors.

Highlights

  • DNA mismatch repair (MMR) deficiency is a major pathway enabling genomic instability in human cancers

  • We found evidence that recurrent encounters with premalignant lesions prime the immune system against microsatellite instability (MSI)-associated tumor antigens in Lynch syndrome (LS) individuals (Figure 5)

  • To verify these hypotheses and gain more confidence in the general character of the findings currently based on colorectal cancers (CRC) and endometrial cancers (EC), studies analyzing immunological features in other MSI tumors of the LS spectrum are warranted

Read more

Summary

Introduction

DNA mismatch repair (MMR) deficiency is a major pathway enabling genomic instability in human cancers. MMR deficiency is characteristic for 15% of colorectal cancers (CRC) and 30% of endometrial cancers (EC) (Figure 1a) [1]. MMR deficiency is caused by the inactivation of one of the MMR genes (MLH1, MSH2, MSH6 and PMS2). As a consequence of non-functional MMR, tumors accumulate insertion/deletion mutations at repetitive microsatellite sequence stretches and present with the microsatellite instability (MSI) phenotype [2]. Accumulate insertion/deletion mutations at repetitive microsatellite sequence stretches and present with the microsatellite instability (MSI) phenotype [2].

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.